Health insurer Cigna profit beats estimates
The health insurer reported higher profit and revenue.
Asia shares fall as markets mull Fed, await China trade meet
Apple is climbing Wednesday after it announced a huge stock repurchase and solid results in its latest quarter, but U.S. stocks are mostly lower as health care firms fall.
Correction: On The Money-Expired Drugs story
Just how firm are expiration dates on bottles of allergy or pain pills?
Ford adds 26,000 vans to recall for fire risk
Ford is expanding a full-size van recall to fix wiring problems that could cause fires, and it's warning drivers to park the vans outside until they're repaired.
CVS beats on profit as prescription sales surge
Net income attributable to the company rose to $998 million, or $0.98 per share, in the first quarter ended March 31 from $952 million, or $0.92 per share, a year earlier.
Health insurer Humana's quarterly profit beats estimates
The fast-growing and profitable Medicare Advantage plans account for about a third of Medicare members, making it an important growth area for private insurers.
Asian shares mostly lower after topsy-turvy day on Wall St
U.S. stocks are slipping Tuesday as first-quarter results from companies including drugmaker Pfizer and athletic apparel maker Under Armour disappointed Wall Street.
Seagate, Pfizer and Cummins skid while AbbVie jumps
Stocks that moved substantially or traded heavily Tuesday: Tapestry Inc., down $6.31 to $47.46 The company's Kate Spade and Stuart Weitzman brands had a weak first quarter.
This cholesterol drug is dropping from $14,600 to as low as $4,500
Regeneron and Sanofi announce rebate deal with benefit manager Express Scripts.
Markets Right Now: Stocks claw back losses, end mostly up
The latest on developments in financial markets (all times local): Stocks are opening moderately lower on Wall Street after several companies reported disappointing results.
Merck posts strong first-quarter profit, but revenue light
Merck is reporting strong profits for the first quarter, but revenue is just shy of what many had expected.
Pfizer's 1Q profit up 14 pct., sales just miss expectations
Pfizer is reporting strong first-quarter profits, but revenue is short of Wall Street expectations.
Sanofi, Regeneron to cut price of heart drug in Express Scripts deal
The drug, Praluent, dramatically lowers bad LDL cholesterol and reduces the risk of heart attacks and death in high-risk heart patients.
Merck posts 1Q beat, powered by Keytruda
Net income fell to $736 million, or 27 cents per share, in the first quarter from $1.55 billion, or 56 cents per share, a year earlier.
Pfizer tops profit estimates, driven by Prevnar sales
The largest U.S. drugmaker said on Tuesday net profit rose to $3.56 billion or 59 cents per share in the first quarter of 2018, from $3.12 billion or 51 cents per share a year earlier.
Recalls this week: ceiling fans, hard hats
More than 100,000 ceiling fans are being recalled because of faulty brackets connecting the fan blades.
Opioid crackdown leaving those who need them out in the cold?
America's opioid epidemic
New Chipotle CEO plans menu 'tweaks,' and maybe drive-thrus
Chipotle, which has been working to revive its business after past food safety scares, says a key sales figure rose as it increased prices in most of its restaurants.
‘Growing Pains’ actor Jeremy Miller credits alcoholism treatment
The implant was an “absolute game changer,” he says.
Medicare hospital prices could soon be posted for patients
CMS administrator Seema Verma said the regulation is part of the effort to make sure patients are put first in health care.
















